Market Outlook
According to the report the global aortic valve replacement devices market is projected to grow at a CAGR of 6.8 % between 2023 and 2028. The market growth is being aided by the growing prevalence of valvular conditions, including aortic regurgitation and aortic stenosis.
In aortic valve replacement procedures, an artificial heart valve is used to replace the patient's failing aortic valve using aortic valve replacement devices. Aortic valve replacements are commonly needed in patients with valvular conditions, such as aortic regurgitation or aortic stenosis. A prosthetic or artificial valve may be used, and it may be made of synthetic materials or tissues from animals. An aortic valve replacement can help promote cardiac muscle function, reduce symptoms, and restore normal blood flow.
The rising frequency of valvular conditions is one of the major factors driving the aortic valve replacement devices market expansion. The market is also being supported by the numerous measures being taken by governments of various nations to treat valvular disorders. The expansion of the market is also significantly impacted by the increasing elderly population. The preferred procedure for extending and enhancing the quality of life for people with valvular disorders is surgical and transcatheter aortic valve replacement (TAVR). These therapeutic approaches enhance patient results and are growing in popularity.
It is anticipated that favourable reimbursement scenarios in various countries and advancements in aortic valve replacement surgery will likely favour the market growth during the forecast period. The introduction of government initiatives to assist the populace by reimbursing a portion of their medical expenses is projected to have a significant positive impact on aortic valve replacement devices market growth throughout the course of the forecast year. With availability of financial support, more patients are likely to proceed with aortic valve replacements.
Based on end use, hospitals make up a significant portion of the market for aortic valve replacement devices. The vast number of patients admitted to hospitals is the primary element sustaining the segment's dominance. This category is projected to grow quickly throughout the projection period due to the fact that hospitals are often the primary source of healthcare in developing nations. As hospitals step up their efforts to offer the public the most modern procedures and services, the market for aortic valve replacement devices is anticipated to grow over the coming few years.
Market Segmentation
The market can be divided on the basis of surgery type, product type, end use, and region.Market Breakup by Surgery Type
- Open Surgery
- Minimally Invasive Surgery
Market Breakup by Product Type
- Transcatheter Aortic Valve
- Sutureless Aortic Valve Replacement (SUAVR)
Market Segmentation by End Use
- Hospital
- Ambulatory Surgical Centres
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Competitive Landscape
This report looks into the market shares, plant turnarounds, capacities, investments, and acquisitions and mergers, among other major developments, of the global aortic valve replacement devices market companies. Some of the major key players explored in the report by the publisher are as follows:- Boston Scientific Corporation
- LivaNova PLC
- Edwards Lifesciences Corporation
- Medtronic PLC
- CryoLife, Inc
- Others
Table of Contents
1 Preface2 Report Coverage - Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Aortic Valve Replacement Devices Market Analysis
8.1 Key Industry Highlights
8.2 Global Aortic Valve Replacement Devices Historical Market (2018-2022)
8.3 Global Aortic Valve Replacement Devices Market Forecast (2023-2028)
8.4 Global Aortic Valve Replacement Devices Market by Surgery Type
8.4.1 Open Surgery
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Minimally Invasive Surgery
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.5 Global Aortic Valve Replacement Devices Market by Product Type
8.5.1 Transcatheter Aortic Valve
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Sutureless Aortic Valve Replacement (SUAVR)
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.6 Global Aortic Valve Replacement Devices Market by End Use
8.6.1 Hospital
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Ambulatory Surgical Centres
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Others
8.7 Global Aortic Valve Replacement Devices Market by Region
8.7.1 North America
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2022)
8.7.1.3 Forecast Trend (2023-2028)
8.7.2 Europe
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2022)
8.7.2.3 Forecast Trend (2023-2028)
8.7.3 Asia Pacific
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2022)
8.7.3.3 Forecast Trend (2023-2028)
8.7.4 Latin America
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2018-2022)
8.7.4.3 Forecast Trend (2023-2028)
8.7.5 Middle East and Africa
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2018-2022)
8.7.5.3 Forecast Trend (2023-2028)
9 North America Aortic Valve Replacement Devices Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Aortic Valve Replacement Devices Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Aortic Valve Replacement Devices Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Aortic Valve Replacement Devices Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Aortic Valve Replacement Devices Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Boston Scientific Corporation
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 LivaNova PLC
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certification
16.2.3 Edwards Lifesciences Corporation
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Medtronic PLC
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 CryoLife, Inc.
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Others
17 Key Trends and Developments in the Market
Companies Mentioned
- Boston Scientific Corporation
- Liva Nova PLC
- Edwards Lifesciences Corporation
- Medtronic PLC
- CryoLife, Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 122 |
| Published | June 2022 |
| Forecast Period | 2023 - 2028 |
| Estimated Market Value ( USD | $ 8986 Million |
| Forecasted Market Value ( USD | $ 12501 Million |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 5 |
